Effect of the Multi‐Strain Probiotic SYN ‐53 in the Management of Allergic Rhinoconjunctivitis
Allergy · 2025
DOI: 10.1111/all.16634 ↗At a glance
Randomisierte kontrollierte Studie in Allergy, 2025. Written by Karl-Christian Bergmann and 1 co-authors. Institution: Institute of Allergology, Charité Universitätsmedizin, Berlin, Germany. Major MEDLINE topics: Probiotics, Conjunctivitis, Allergic, Rhinitis, Allergic, Rhinitis, Allergic, Seasonal. Cited 4 times so far (Crossref); 33 references. The full text is freely available (open access, CC BY 4.0). Funded by: Synformulas.
Abstract (original language)
Dysbiosis is increasingly linked to allergy development. This study evaluates the efficacy of the multi‐strain probiotic SYN‐53 in the management of allergic rhinoconjunctivitis (ARC). Eighty‐four subjects with confirmed grass pollen allergy underwent up to three bi‐weekly 3‐day intake cycles with SYN‐53 or placebo. After each cycle, subjects were exposed to grass pollen in an allergen exposure chamber. ARC symptoms were assessed using the Total Symptom Score (TSS) before and after each use of SYN‐53. After one intake cycle, SYN‐53 already showed a trend towards greater efficacy over placebo, which became significant after two cycles (ΔTSS MAX : −3.44 ± 0.42 vs. −1.87 ± 0.37; p = 0.0067), with 38% vs. 24% symptom relief. In subjects with moderate to severe symptoms, SYN‐53 was already significantly superior after one single intake cycle and improved further after two cycles (ΔTSS MAX : −4.78 ± 0.51 vs. −2.43 ± 0.47; p = 0.0014), with 45% vs. 26% symptom relief. SYN‐53 is effective in the management of ARC, highlighting the role of bacterial diversity and dosage in probiotic nutritional supplements.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Institute of Allergology, Charité Universitätsmedizin, Berlin, Germany.
- Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, Berlin, Germany.
- Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany.
ORCID profiles: Torsten Zuberbier
Funding
- Synformulas
Cite
APA
Bergmann, K. C., & Zuberbier, T. (2025). Effect of the Multi‐Strain Probiotic SYN ‐53 in the Management of Allergic Rhinoconjunctivitis. Allergy. https://doi.org/10.1111/all.16634
Vancouver
Bergmann KC, Zuberbier T. Effect of the Multi‐Strain Probiotic SYN ‐53 in the Management of Allergic Rhinoconjunctivitis. Allergy. 2025. doi:10.1111/all.16634
BibTeX
@article{Bergmann2025,
author = {Bergmann, Karl-Christian and Zuberbier, Torsten},
title = {Effect of the Multi‐Strain Probiotic SYN ‐53 in the Management of Allergic Rhinoconjunctivitis},
journal = {Allergy},
year = {2025},
doi = {10.1111/all.16634}
}
EUVIMED